A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma.

H Kang, AL Ho, J Muzaffar, DW Bowles, SB Kim… - 2020 - ascopubs.org
TPS6597 Background: Adenoid cystic carcinoma (ACC) is a rare salivary gland malignancy,
also found in other secretory gland sites (tracheobronchial tree, esophagus, breast, lungs …
被引用次数：2 相关文章

[引用][C] A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma.

H Kang, AL Ho, J Muzaffar, DW Bowles… - JOURNAL OF …, 2020 - scholarworks.bwise.kr
ScholarWorks@SUNGKYUNKWAN UNIVERSITY: A phase II open-label, multicenter, study to
evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid …